Nicole Erin Kinsey White

Array ( [id] => 4624018 [patent_doc_number] => 08003313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Method for detecting and removing endotoxin' [patent_app_type] => utility [patent_app_number] => 11/814358 [patent_app_country] => US [patent_app_date] => 2006-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15087 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003313.pdf [firstpage_image] =>[orig_patent_app_number] => 11814358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154366 [patent_doc_number] => 20070037249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Molecules that block viral infectivity and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/327626 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13770 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037249.pdf [firstpage_image] =>[orig_patent_app_number] => 11327626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173548 [patent_doc_number] => 07658927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Materials and methods for immunizing against FIV infection' [patent_app_type] => utility [patent_app_number] => 11/326062 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20839 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/658/07658927.pdf [firstpage_image] =>[orig_patent_app_number] => 11326062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8457615 [patent_doc_number] => 08293280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Method for treatment of HIV infection' [patent_app_type] => utility [patent_app_number] => 11/792334 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5219 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11792334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82679 [patent_doc_number] => 07740855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Inactivated CD8+ T-cells for the treatment of HIV infection' [patent_app_type] => utility [patent_app_number] => 11/290682 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10389 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740855.pdf [firstpage_image] =>[orig_patent_app_number] => 11290682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771403 [patent_doc_number] => 20080057061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Method of Treating Diseases and Disorders' [patent_app_type] => utility [patent_app_number] => 11/791360 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20124 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057061.pdf [firstpage_image] =>[orig_patent_app_number] => 11791360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959715 [patent_doc_number] => 20080274140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Vaccines and Methods for Using the Same' [patent_app_type] => utility [patent_app_number] => 11/719646 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11582 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274140.pdf [firstpage_image] =>[orig_patent_app_number] => 11719646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588085 [patent_doc_number] => 20100291537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'METHODS AND COMPOSITIONS RELATED TO PHAGE-NANOPARTICLE ASSEMBLIES' [patent_app_type] => utility [patent_app_number] => 11/719508 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 24326 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291537.pdf [firstpage_image] =>[orig_patent_app_number] => 11719508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278064 [patent_doc_number] => 20090130196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Bacteriophage composition' [patent_app_type] => utility [patent_app_number] => 11/666704 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10579 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130196.pdf [firstpage_image] =>[orig_patent_app_number] => 11666704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230283 [patent_doc_number] => 20070292390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies' [patent_app_type] => utility [patent_app_number] => 11/718202 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13018 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292390.pdf [firstpage_image] =>[orig_patent_app_number] => 11718202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857862 [patent_doc_number] => 20060228333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Methods for control of tumors and chronic infections by modulating immunologically informed carriers homing to tolerogenic organs or tissues' [patent_app_type] => utility [patent_app_number] => 11/254063 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7406 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228333.pdf [firstpage_image] =>[orig_patent_app_number] => 11254063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613947 [patent_doc_number] => 20060115875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Detection, characterization and treatment of viral infection and methods thereof' [patent_app_type] => utility [patent_app_number] => 11/248008 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 29495 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115875.pdf [firstpage_image] =>[orig_patent_app_number] => 11248008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 567354 [patent_doc_number] => 07462485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Modified erythrocytes and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/245074 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7327 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462485.pdf [firstpage_image] =>[orig_patent_app_number] => 11245074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4915138 [patent_doc_number] => 20080095738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Vlp-Antigen Conjugates and Their Uses as Vaccines' [patent_app_type] => utility [patent_app_number] => 11/664716 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 36486 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095738.pdf [firstpage_image] =>[orig_patent_app_number] => 11664716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11450345 [patent_doc_number] => 09573979 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-21 [patent_title] => 'Modified VP1-capsid protein of parvovirus B19' [patent_app_type] => utility [patent_app_number] => 11/575951 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 8616 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11575951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791679 [patent_doc_number] => 20080292652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Virus-Like Particles Comprising a Fusion Protein of the Coat Protein of Ap205 and an Antigenic Polypeptide' [patent_app_type] => utility [patent_app_number] => 11/663350 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24529 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292652.pdf [firstpage_image] =>[orig_patent_app_number] => 11663350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183010 [patent_doc_number] => 20070054357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Identification of useful bacteriophage' [patent_app_type] => utility [patent_app_number] => 11/220076 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13901 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054357.pdf [firstpage_image] =>[orig_patent_app_number] => 11220076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710981 [patent_doc_number] => 20060052326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Werner\'s syndrome helicase as a target for anti -HIV/AIDS therapy' [patent_app_type] => utility [patent_app_number] => 11/213359 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12513 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052326.pdf [firstpage_image] =>[orig_patent_app_number] => 11213359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626011 [patent_doc_number] => 08795685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Mutated HIV Nef for modulating immunity' [patent_app_type] => utility [patent_app_number] => 11/660449 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 11189 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11660449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028012 [patent_doc_number] => 20070269459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Mutant G Genes of the Trout Viral Haemorrhagic Septicaemia Virus (Vhsv) and Applications Thereof' [patent_app_type] => utility [patent_app_number] => 11/574369 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11302 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269459.pdf [firstpage_image] =>[orig_patent_app_number] => 11574369 [rel_patent_id] =>[rel_patent_doc_number] =>)